OFG
GSK icon

OmniStar Financial Group’s GSK GSK Stock Holding History

OmniStar Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,778
Closed -$585K – 129
2023
Q4 		$585K Buy
15,778
+211
+1% +$7.58K 0.73% 52
2023
Q3 		$565K Sell
15,567
-4,361
-22% -$155K 0.67% 51
2023
Q2 		$710K Sell
19,928
-1,235
-6% -$44.3K 0.83% 43
2023
Q1 		$753K Sell
21,163
-502
-2% -$17.6K 0.96% 34
2022
Q4 		$761K Buy
+21,665
New +$722K 0.87% 43
2022
Q3 		– Sell
-8,811
Closed -$479K – 115
2022
Q2 		$479K Sell
8,811
-891
-9% -$49.2K 0.53% 69
2022
Q1 		$528K Sell
9,702
-72
-0.7% -$3.91K 0.52% 73
2021
Q4 		$538K Buy
+9,774
New +$508K 0.55% 69
2021
Q2 		– Sell
-9,626
Closed -$463K – 129
2021
Q1 		$429K Sell
9,626
-4,184
-30% -$190K 0.55% 66
2020
Q4 		$635K Sell
13,810
-2,659
-16% -$122K 0.45% 70
2020
Q3 		$775K Buy
16,469
+1,361
+9% +$68.2K 0.58% 56
2020
Q2 		$770K Buy
15,108
+1,897
+14% +$97.3K 0.64% 58
2020
Q1 		$626K Sell
13,211
-11,815
-47% -$630K 0.62% 53
2019
Q4 		$1.47M Buy
25,026
+571
+2% +$31.8K 1.24% 26
2019
Q3 		$1.3M Buy
24,455
+257
+1% +$13.2K 1.14% 35
2019
Q2 		$1.21M Buy
24,198
+472
+2% +$23.7K 1.09% 39
2019
Q1 		$1.24M Buy
23,726
+752
+3% +$37.6K 1.09% 40
2018
Q4 		$1.1M Buy
22,974
+16,016
+230% +$789K 1.12% 40
2018
Q3 		$349K Buy
6,958
+1,547
+29% +$78.6K 0.27% 109
2018
Q2 		$272K Sell
5,411
-1,451
-21% -$73.1K 0.26% 94
2018
Q1 		$335K Buy
6,862
+797
+13% +$37.1K 0.32% 80
2017
Q4 		$268K Buy
+6,065
New +$280K 0.25% 93

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OmniStar Financial Group's GSK Position: Q1 2024 in Review

OmniStar Financial Group sold out of GSK (GSK) in Q1 2024, closing a stake of 15,778 shares — an estimated $585K sold.

OmniStar Financial Group first reported a position in GSK in Q4 2017 and held it in 22 quarters. The position peaked at $1.47M in Q4 2019. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • OmniStar Financial Group reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
  • OmniStar Financial Group sold 15,778 GSK shares in Q1 2024, an estimated $585K.
  • OmniStar Financial Group first reported a position in GSK in Q4 2017 and held it in 22 quarters.
  • OmniStar Financial Group's GSK position peaked at $1.47M in Q4 2019.
  • 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on OmniStar Financial Group's 13F filing for Q1 2024, filed 23 Apr 2024.